[
  {
    "variant_id": {
      "Gene": "a-synuclein",
      "Protein_Change": {
        "ref": "A",
        "alt": "T",
        "position": "53"
      },
      "variant_string_id": "a-synuclein A53T"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant. The disease mechanism is the fibrillization of a-synuclein and tau proteins in familial Parkinson’s disease caused by the A53T a-syn mutation.",
        "judgment": "Yes",
        "reasoning": "The paper clearly describes the deposition of filamentous insoluble proteins, specifically a-synuclein and tau, in the form of Lewy bodies (LBs) or inclusions in neuronal processes as the pathological hallmark of Parkinson’s disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The general class of assays used for this variant include immunohistochemical, biochemical and ultrastructural analysis. These assays effectively model or reflect the disease pathogenesis/mechanism defined in Step 1 as they are directly measuring the fibrillization of a-synuclein and tau proteins.",
        "judgment": "Yes"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "sub_steps": [
          {
            "sub_step_name": "3a. Basic Controls and Replicates",
            "questions": [
              {
                "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                "answer": "Yes"
              },
              {
                "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                "answer": "Yes"
              }
            ],
            "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
          },
          {
            "sub_step_name": "3b. Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a).",
            "questions": [
              {
                "question": "Has the specific instance of the assay been: a) Broadly accepted historically (e.g., standard technique in the field)? OR b) Previously validated in other studies (cited)? OR c) Provided as a commercial kit with defined performance metrics, *but* where controls/replicates are not documented for the specific instance of the assay in *this* paper?",
                "answer": "Yes"
              }
            ],
            "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
          },
          {
            "sub_step_name": "3c. Variant Controls (if basic controls/replicates were sufficient in 3a).",
            "questions": [
              {
                "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria *without* relying on PS3/BS3 evidence themselves?",
                "answer": "Yes"
              }
            ],
            "judgment": "Proceed to Step 4."
          },
          {
            "sub_step_name": "4a. Statistical Analyses",
            "questions": [
              {
                "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                "answer": "Yes"
              }
            ],
            "judgment": "Proceed to Sub-step 4c."
          },
          {
            "sub_step_name": "4b. No OddsPath Calculation (if statistical analyses were insufficient).",
            "questions": [],
            "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
          },
          {
            "sub_step_name": "4c. Correlate OddsPath (if statistical analyses were sufficient).",
            "questions": [],
            "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
          }
        ]
      }
    ],
    "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
  }
]